The most effective treatment for neuropathy varies from person to person. Treatment often depends on the underlying cause of the neuropathy, such as vitamin B12 deficiency or diabetes. While ...

Google is ramping up its artificial intelligence efforts in India to integrate AI across its products for Indians — a move that escalates the growing rivalry among U.S. tech firms in a market ...

Learn more Consistent flea prevention and control are key to supporting your cat's health and wellness. With the best flea and tick treatments for cats, you can safely and effectively prevent and ...

If you look at all the best pets in Hollywood history, it doesn’t all that long to come up with a handful (or a few handfuls) of iconic cats from yesterday and today. However, while all the ...

Experts expressed enthusiasm Friday after US health regulators approved the first new form of treatment for schizophrenia in decades. The drug, called Cobenfy and developed by US pharma giant Bristol ...

Researchers from the University of Montreal have created a first-of-its-kind electrode-lined crochet beanie that can be used to measure a cat’s brain activity. Aside from being adorable ...

No new treatments for schizophrenia have been approved in nearly three decades, but that changed on Sept. 26, when the U.S. Food and Drug Administration (FDA) approved Cobenfy for the psychiatric ...

According to the authors, one-quarter of adult cats suffer from osteoarthritis and chronic pain that worsens with age. There are currently limited treatment options, namely, non-steroidal anti ...

A high-tech kind of radiation designed for people is also being used for dogs and cats with cancer. The only dedicated veterinary center providing this treatment is in Malvern, Pennsylvania.

If you provide methadone treatment or other substance-use disorder treatments in jails, will it reduce people from going back to jail? Several University of New Mexico researchers say yes.

The first new kind of treatment for schizophrenia patients in decades is arriving. The U.S. Food and Drug Administration approved the drug on Thursday, greenlighting the first of a new class of ...

Jiwon Oh, MD, PhD, reporting from ECTRIMS 2024, emphasizes the significance of findings on disease-modifying treatments in MS. Key studies, including the phase 3 GEMINI 1 and GEMINI 2 trials on ...